Inst Diagnosti (SN:INDISA) — Market Cap & Net Worth
Market Cap & Net Worth: Inst Diagnosti (INDISA)
Inst Diagnosti (SN:INDISA) has a market capitalization of $463.12 Million (CL$414.11 Billion) as of June 17, 2026. Listed on the SN stock exchange, this Chile-based company holds position #12854 globally and #55 in its home market, demonstrating a -0.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inst Diagnosti's stock price CL$2699.00 by its total outstanding shares 153430266 (153.43 Million). Review total liabilities of Inst Diagnosti to assess the company's total debt and financial obligations.
Inst Diagnosti Market Cap History: 2015 to 2026
Inst Diagnosti's market capitalization history from 2015 to 2026. Data shows growth from $236.08 Million to $463.12 Million (6.04% CAGR).
Inst Diagnosti Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inst Diagnosti's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Inst Diagnosti's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.03x
Inst Diagnosti's market cap is 0.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $310.78 Million | $128.31 Billion | $12.93 Billion | 0.00x | 0.02x |
| 2017 | $355.64 Million | $138.35 Billion | $11.89 Billion | 0.00x | 0.03x |
| 2018 | $339.05 Million | $145.41 Billion | $14.70 Billion | 0.00x | 0.02x |
| 2019 | $265.90 Million | $150.19 Billion | $11.63 Billion | 0.00x | 0.02x |
| 2020 | $235.96 Million | $139.36 Billion | $3.50 Billion | 0.00x | 0.07x |
| 2021 | $253.74 Million | $188.54 Billion | $20.65 Billion | 0.00x | 0.01x |
| 2022 | $270.41 Million | $191.29 Billion | $13.05 Billion | 0.00x | 0.02x |
| 2023 | $216.69 Million | $218.93 Billion | $144.31 Million | 0.00x | 1.50x |
| 2024 | $269.39 Million | $239.07 Billion | $7.28 Billion | 0.00x | 0.04x |
| 2025 | $492.47 Million | $272.31 Billion | $15.66 Billion | 0.00x | 0.03x |
Competitor Companies of INDISA by Market Capitalization
Companies near Inst Diagnosti in the global market cap rankings as of June 17, 2026.
Key companies related to Inst Diagnosti by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Inst Diagnosti Historical Marketcap From 2015 to 2026
Between 2015 and today, Inst Diagnosti's market cap moved from $236.08 Million to $ 463.12 Million, with a yearly change of 6.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CL$463.12 Million | -5.96% |
| 2025 | CL$492.47 Million | +82.81% |
| 2024 | CL$269.39 Million | +24.32% |
| 2023 | CL$216.69 Million | -19.87% |
| 2022 | CL$270.41 Million | +6.57% |
| 2021 | CL$253.74 Million | +7.54% |
| 2020 | CL$235.96 Million | -11.26% |
| 2019 | CL$265.90 Million | -21.58% |
| 2018 | CL$339.05 Million | -4.66% |
| 2017 | CL$355.64 Million | +14.43% |
| 2016 | CL$310.78 Million | +31.64% |
| 2015 | CL$236.08 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Inst Diagnosti was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $463.12 Million USD |
| MoneyControl | $463.12 Million USD |
| MarketWatch | $463.12 Million USD |
| marketcap.company | $463.12 Million USD |
| Reuters | $463.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more